Gallus picks ‘game-changing’ bioreactor by Sartorius’s TAP Biosystems
Gallus BioPharmaceuticals has chosen TAP Biosystems, acquired last October by the Sartorius Stedim Biotech Group, to provide single-use bioreactors for its latest facility.
Archives for May 19, 2014
Survey finds solid base for early phase cell therapy manufacturing in UK
The UK manufacturing sector covers all of its bases in terms of the current cell therapy manufacturing requirements and includes “a strong manufacturing base” to bring early phase academic research into the clinic, according to a survey conducted by Cell...
Scientists look to deliver gene therapy via polymer nanoparticles
Scientists in the US report that gene therapy could be delivered using plastic biodegradable nanoparticles